Geneesmiddelenbeleid
This procedure concerns a motion regarding the national policy for pharmaceuticals. It focuses on how the government manages the availability, pricing, and distribution of medicines to ensure public health and sustainable healthcare spending. This affects healthcare providers, pharmaceutical companies, and patients who rely on the accessibility and affordability of essential medications.
National vote coverage: Netherlands-only